BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Neocentromeres, Rapamycin, rs7903146, MDM2, nitric oxide metabolic process, Ischemia)
Bookmark Forward

QuickView for dipeptidyl peptidase 4 inhibitors (compound)


Genetic Markers

Most Correlated Genes

  1. SFTPA2
  2. VCAM1
  3. ERAP2
  4. SFTPB
  5. CPVL
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. cytosol
  2. regulation of nitrogen compound metabolic process
  3. BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
  4. organic cyclic compound metabolic process
  5. organic cyclic compound binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Gliptin-induced bullous pemphigoid.
  2. Identification of levomenthol derivatives as potential dipeptidyl peptidase-4 inhibitors: a comparat…
  3. Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients.
  4. Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease
  5. Gliptin-Induced Bullous Pemphigoid: Canadian Case Series of 10 Patients.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
  2. Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Athe…
  3. Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
  4. The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors
  5. Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.